COVID-19 : management and infection control
© 2021 Published by Elsevier Ltd..
The coronavirus disease 2019 (COVID-19) pandemic has caused more than 4.5 million deaths worldwide to date. The emergence of the novel severe acute respiratory syndrome coronavirus 2 has created immense pressure on health services and complex challenges in public health. Essential features in managing COVID-19 include best-practice care for the individual but also minimizing exposure to uninfected patients, staff and the wider community. The central tenets in limiting disease transmission involves strict infection and prevention control, categorizing COVID-19 cases as possible, probable or confirmed, alongside contact tracing, isolation, hand hygiene and droplet precautions.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:49 |
---|---|
Enthalten in: |
Medicine (Abingdon, England : UK ed.) - 49(2021), 12 vom: 01. Dez., Seite 794-796 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Harte, Jeffrey [VerfasserIn] |
---|
Links: |
---|
Themen: |
COVID-19 |
---|
Anmerkungen: |
Date Revised 29.11.2021 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.1016/j.mpmed.2021.09.014 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM331260247 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM331260247 | ||
003 | DE-627 | ||
005 | 20231225213055.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.mpmed.2021.09.014 |2 doi | |
028 | 5 | 2 | |a pubmed24n1104.xml |
035 | |a (DE-627)NLM331260247 | ||
035 | |a (NLM)34584489 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Harte, Jeffrey |e verfasserin |4 aut | |
245 | 1 | 0 | |a COVID-19 |b management and infection control |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 29.11.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a © 2021 Published by Elsevier Ltd. | ||
520 | |a The coronavirus disease 2019 (COVID-19) pandemic has caused more than 4.5 million deaths worldwide to date. The emergence of the novel severe acute respiratory syndrome coronavirus 2 has created immense pressure on health services and complex challenges in public health. Essential features in managing COVID-19 include best-practice care for the individual but also minimizing exposure to uninfected patients, staff and the wider community. The central tenets in limiting disease transmission involves strict infection and prevention control, categorizing COVID-19 cases as possible, probable or confirmed, alongside contact tracing, isolation, hand hygiene and droplet precautions | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a SARS-CoV-2 | |
650 | 4 | |a infection and prevention control | |
650 | 4 | |a public health | |
650 | 4 | |a vaccines | |
700 | 1 | |a Hamzah, Lisa |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Medicine (Abingdon, England : UK ed.) |d 1998 |g 49(2021), 12 vom: 01. Dez., Seite 794-796 |w (DE-627)NLM094498857 |x 1357-3039 |7 nnns |
773 | 1 | 8 | |g volume:49 |g year:2021 |g number:12 |g day:01 |g month:12 |g pages:794-796 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.mpmed.2021.09.014 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 49 |j 2021 |e 12 |b 01 |c 12 |h 794-796 |